Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Fluticasone vs Salmeterol/Fluticasone in COPD
NCT00549146Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Apr 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00549146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549146.